La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MDxHealth a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MDxHealth..

MDxHealth (NASDAQ:MDXH) Azioni, Catena delle Opzioni

MDxHealth

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Keefe, Bruyette &amp; Woods analyst Bose George downgrades UWM Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UWMC#NYSE">UWMC</a>) from Outperform to Market Perform and lowers the price target from $6.5 to $4.5.

News

Downgrades

Price Target

Analyst Ratings

UWMC

Keefe, Bruyette & Woods Downgrades UWM Holdings to Market Perform, Lowers Price Target to $4.5

Events

Live On CNBC, MP Materials CEO Says "This Is Not A Nationalization, We Remain A Thriving Public Company"

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $248 to $249.

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $249

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Sunrise Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNS#NASDAQ">SUNS</a>) with a Outperform and raises the price target from $10.75 to $11.5.

SUNS

Keefe, Bruyette & Woods Maintains Outperform on Sunrise Realty Trust, Raises Price Target to $11.5

Wells Fargo analyst Elyse Greenspan maintains Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Equal-Weight and raises the price target from $113 to $116.

Wells Fargo Maintains Equal-Weight on Prudential Financial, Raises Price Target to $116

<a href="https://www.marijuanamoment.net/california-senators-approve-bill-to-pause-newly-enacted-marijuana-tax-hike-for-five-years/" title="https://www.marijuanamoment.net/california-senators-approve-bill-to-pause-newly-enacted-marijuana-tax-hike-for-five-years/">https://www.marijuanamoment.net/california-senators-approve-bill-to-pause-newly-enacted-marijuana-tax-hike-for-five-years/</a>

Macro Economic Events

Politics

Global

Economics

General

AKAN

CRON

GRWG

IMCC

LFLY

MSOS

SNDL

TLRY

'California Senators Approve Bill To Pause Newly Enacted Marijuana Tax Hike For Five Years' - Marijuana Moment

Needham analyst Scott Berg reiterates Amplitude (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPL#NASDAQ">AMPL</a>) with a Buy and maintains $16 price target.

Reiteration

AMPL

Needham Reiterates Buy on Amplitude, Maintains $16 Price Target

<a href="https://www.youtube.com/watch?v=K0UwLfevw24">https://www.youtube.com/watch?v=K0UwLfevw24</a>

Fed's Musalem Says So Far The Tariff Impact On Prices Appears To Be Mild, Though It Is Early In The Process

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Starwood Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) with a Outperform and raises the price target from $21 to $22.

STWD

Keefe, Bruyette & Woods Maintains Outperform on Starwood Property Trust, Raises Price Target to $22

Wells Fargo analyst Elyse Greenspan maintains Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) with a Underweight and raises the price target from $69 to $73.

Wells Fargo Maintains Underweight on Principal Financial Group, Raises Price Target to $73

<a href="https://www.bloomberg.com/news/articles/2025-07-10/huawei-seeks-ai-chip-customers-in-middle-east-southeast-asia" title="https://www.bloomberg.com/news/articles/2025-07-10/huawei-seeks-ai-chip-customers-in-middle-east-southeast-asia">https://www.bloomberg.com/news/articles/2025-07-10/huawei-seeks-ai-chip-customers-in-middle-east-southeast-asia</a>

'Huawei Seeks AI Chip Customers in Middle East, Southeast Asia' - Bloomberg News

WIIM

TNXP

Tonix Pharmaceuticals shares are trading higher after the company announced the presentation of new findings on TNX-801 at the Vaccine Congress 2025 in Vienna.

Keefe, Bruyette &amp; Woods analyst Bose George maintains Stewart Information Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STC#NYSE">STC</a>) with a Market Perform and lowers the price target from $75 to $72.

Keefe, Bruyette & Woods Maintains Market Perform on Stewart Information Servs, Lowers Price Target to $72

Fed's Musalem Says Not Hearing From Firms That There Are Supply Chain Disruptions

Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and raises the price target from $94 to $97.

Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $97

XCF Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFX#NASDAQ">SAFX</a>) stock is trading higher on Thursday, with a session volume of 95.7 million compared to the average volume of 6.21 million <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">as per data from Benzinga Pro</a>.
A key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (SAF), the company shared its strategic plan to invest close to $1 billion in developing a network of SAF production facilities, expanding its U.S. footprint, and advancing its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/ac46339803/xcf-global-outlines-plan-to-build-multiple-saf-production-facilities-and-invest-nearly-1-billion-" rel="noreferrer noopener">international growth strategy</a>.
From inception, approximately $350 million has been invested to bring New Rise Reno online which has created approximately 60 full-time management, engineering, and related jobs in the Reno-Tahoe area.
Also Read: <a href="https://www.benzinga.com/node/46338975">Top 3 Energy Stocks Which Could Rescue Your Portfolio For July</a>
More than 2 billion people globally live in countries with SAF blending mandates or strong incentives like tax credits &#8211; by 2030, this number is expected to grow to more than 4 billion people.
Expanding global demand underpins XCF&#8217;s decision to scale production at home and internationally, ensuring the company is positioned to serve markets where policy, aviation demand, and decarbonization goals align.
&#8220;We&#8217;re not simply dreaming about decarbonizing the aviation industry &#8211; we&#8217;re building it right now,&#8221; said Mihir Dange, Chief Executive Officer and Board Chair of XCF. &#8220;With over $350 million already invested through New Rise Reno, we&#8217;ve proven that we can bring large-scale, commercial SAF production online. Our strategy is to invest nearly $1 billion over the next three years to develop multiple production facilities that will deliver real volumes, real revenue, and real impact for our shareholders.&#8221;
<h2 class="wp-block-heading">U.S. Growth Pipeline</h2>
XCF&#8217;s U.S. expansion plan includes three additional production sites that have already been acquired and are ready for development. Each facility is expected to have a nameplate production capacity of 40 million gallons. 
Together with New Rise Reno, these sites are expected to deliver a total production capacity of approximately 160 million gallons per year by the end of 2028.
The first new facility, New Rise Reno 2, will be adjacent to the existing New Rise Reno facility, enabling economies of scale and leveraging shared utilities and logistics infrastructure; this facility is expected to be completed in 2027. 
The second facility will be in Ft. Myers, Florida, chosen due to growing SAF demand in the Southeast U.S. and access to port infrastructure; this facility is expected to be completed by 2028. 
Finally, the third facility will be in Wilson, North Carolina, strategically located to serve East Coast markets and support local economic development; this facility is also expected to be completed by 2028.
<h2 class="wp-block-heading">International Expansion Strategy</h2>
In addition to its U.S. pipeline, XCF is pursuing an international growth strategy to expand its platform into high-potential global markets.
The company recently signed a Memorandum of Understanding (MOU) to launch New Rise Australia, a new SAF and renewable diesel production platform in partnership with Continual Renewable Ventures.
Price Action: SAFX stock is trading higher by 70.7% to $2.56 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46344382/united-airlines-american-airlines-stocks-rise-on-deltas-bullish-forecast" target="_blank" rel="noreferrer noopener">United Airlines, American Airlines Stocks Rise On Delta&#8217;s Bullish Forecast</a></li>
</ul>
Image via Shutterstock

Movers

SAFX

XCF Global Bets Big On Sustainable Aviation Fuel With $1 Billion Investment

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Underperform and raises the price target from $9 to $13.

SOFI

Keefe, Bruyette & Woods Maintains Underperform on SoFi Technologies, Raises Price Target to $13

Wells Fargo analyst Elyse Greenspan maintains Lincoln National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>) with a Equal-Weight and raises the price target from $33 to $35.

Wells Fargo Maintains Equal-Weight on Lincoln National, Raises Price Target to $35

Wells Fargo analyst Elyse Greenspan maintains Globe Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) with a Overweight and raises the price target from $139 to $144.

Wells Fargo Maintains Overweight on Globe Life, Raises Price Target to $144

Keefe, Bruyette &amp; Woods analyst Bose George downgrades Redwood Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RWT#NYSE">RWT</a>) from Outperform to Market Perform and lowers the price target from $7 to $6.5.

Comments

MDxHealth

MDxHealth (MDXH) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO